Exploring Hypertrophic Cardiomyopathy Biomarkers through Integrated Bioinformatics Analysis: Uncovering Novel Diagnostic Candidates
HCM is a heterogeneous monogenic cardiac disease that can lead to arrhythmia, heart failure, and atrial fibrillation. This study aims to identify biomarkers that have a positive impact on the treatment, diagnosis, and prediction of HCM through bioinformatics analysis. We selected the GSE36961 and GS...
Saved in:
Main Authors: | Guanmou Li, Dongqun Lin, Xiaoping Fan, Bo Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2024/4639334 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sepsis-induced suicidal left ventricular in a patient with hypertrophic cardiomyopathy/hypertrophic obstructive cardiomyopathy
by: K Roshan Rao, et al.
Published: (2022-01-01) -
Pediatric hypertrophic cardiomyopathy caused by a novel TNNI3 variant
by: Natsuko Inagaki, et al.
Published: (2024-03-01) -
Clinical burden of obstructive hypertrophic cardiomyopathy in France
by: Philippe Charron, et al.
Published: (2025-01-01) -
Efficacy of Novel Noncontrast Cardiac Magnetic Resonance Methods in Indicating Fibrosis in Hypertrophic Cardiomyopathy
by: Maedeh Sharifian, et al.
Published: (2021-01-01) -
An Unusual Presentation of a Myocardial Crypt in Hypertrophic Cardiomyopathy
by: Danny A. J. P. van de Sande, et al.
Published: (2014-01-01)